These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5494513)

  • 1. Accumulation of (3',5'-3H2)folic acid by human blood platelets. Effect of dihydrofolic acid reductase inhibitors.
    Gaut ZN; Solomon HM; Baugh CM
    Biochim Biophys Acta; 1970 Jul; 215(1):194-7. PubMed ID: 5494513
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antimetabolites of folic acid metabolism with chemotherapeutic activity against rodent malaria (Plasmodium vinckei)].
    Heischkeil R
    Z Tropenmed Parasitol; 1973 Dec; 24(4):505-16. PubMed ID: 4778588
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential antileprotic agents. 2. Inhibition of mycobacterial dihydrofolic reductase.
    DeGraw JI; Brown VH; Colwell WT; Morrison NE
    J Med Chem; 1974 Jan; 17(1):144-6. PubMed ID: 4585973
    [No Abstract]   [Full Text] [Related]  

  • 4. Two different effects of mutation on the binding of folate antagonists by a microbial dihydrofolate reductase.
    Sirotnak FM
    Biochim Biophys Acta; 1973 Mar; 302(1):13-23. PubMed ID: 4144236
    [No Abstract]   [Full Text] [Related]  

  • 5. FURTHER OBSERVATIONS OF THE BINDING AND INHIBITION OF DIHYDROFOLIC REDUCTASE BY FOLIC ACID ANTAGONISTS.
    SCHRECKER AW; HUENNEKENS FM
    Biochem Pharmacol; 1964 May; 13():731-42. PubMed ID: 14181276
    [No Abstract]   [Full Text] [Related]  

  • 6. Active-site directed irreversible inhibitors of dihydrofolate reductase.
    Baker BR
    Ann N Y Acad Sci; 1971 Nov; 186():214-26. PubMed ID: 4943574
    [No Abstract]   [Full Text] [Related]  

  • 7. Methotrexate and aminopterin lack in vivo antimalarial activity against murine malaria species.
    Irungu B; Kiboi D; Langat B; Rukunga G; Wittlin S; Nzila A
    Exp Parasitol; 2009 Oct; 123(2):118-21. PubMed ID: 19527714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydrofolate reductase from Trypanosoma equiperdum. I. Isolation, partial purification, and properties.
    Jaffe JJ; McCormack JJ
    Mol Pharmacol; 1967 Jul; 3(4):359-69. PubMed ID: 4382281
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of dihydrofolic reductase by aminopterin and amethopterin.
    OSBORN MJ; FREEMAN M; HUENNEKENS FM
    Proc Soc Exp Biol Med; 1958 Feb; 97(2):429-31. PubMed ID: 13518295
    [No Abstract]   [Full Text] [Related]  

  • 10. Competitive inhibition of folate absorption by dihydrofolate reductase inhibitors, trimethoprim and pyrimethamine.
    Zimmerman J; Selhub J; Rosenberg IH
    Am J Clin Nutr; 1987 Sep; 46(3):518-22. PubMed ID: 3630970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of sulfa drugs and dihydrofolate reductase inhibitors against Candida albicans.
    Bush K; Freudenberger JS; Slusarchyk DS; Sykes RB; Meyers E
    Experientia; 1982 Apr; 38(4):436-7. PubMed ID: 7044814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of folate antagonists on the metabolism of folic acid and its reduced derivatives in rat liver and kidney.
    Bühring U; Shin YS; Fölsch E
    Cancer Res; 1977 Jan; 37(1):299-304. PubMed ID: 830415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of pyrimethamine-induced megaloblastosis in human bone marrow.
    Waxman S; Herbert V
    N Engl J Med; 1969 Jun; 280(24):1316-9. PubMed ID: 5771778
    [No Abstract]   [Full Text] [Related]  

  • 14. Characteristics of folic acid transport in the L1210 leukemia cell.
    Lichtenstein NS; Oliverio VT; Goldman ID
    Biochim Biophys Acta; 1969; 193(2):456-67. PubMed ID: 5389249
    [No Abstract]   [Full Text] [Related]  

  • 15. A model system for the study of heteroexchange diffusion: methotrexate-folate interactions in L1210 leukemia and Ehrlich ascites tumor cells.
    Goldman ID
    Biochim Biophys Acta; 1971 Jun; 233(3):624-34. PubMed ID: 5113921
    [No Abstract]   [Full Text] [Related]  

  • 16. Stereochemical characteristics of the folate-antifolate transport mechanism in L1210 Leukemia cells.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1974 Feb; 34(2):371-7. PubMed ID: 4855750
    [No Abstract]   [Full Text] [Related]  

  • 17. Carrier-mediated transport of folic acid in BeWo cell monolayers as a model of the human trophoblast.
    Takahashi T; Utoguchi N; Takara A; Yamamoto N; Nakanishi T; Tanaka K; Audus KL; Watanabe Y
    Placenta; 2001 Nov; 22(10):863-9. PubMed ID: 11718574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple mechanisms of resistance to polyglutamatable and lipophilic antifolates in mammalian cells: role of increased folylpolyglutamylation, expanded folate pools, and intralysosomal drug sequestration.
    Jansen G; Barr H; Kathmann I; Bunni MA; Priest DG; Noordhuis P; Peters GJ; Assaraf YG
    Mol Pharmacol; 1999 Apr; 55(4):761-9. PubMed ID: 10101035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new cytochemical method for the study of the tetrahydrofolatereductase activity in Plasmodium berghei: analysis of the effect of specific inhibitors].
    Gerzeli G; Polver Pde P
    Riv Parassitol; 1969 Mar; 30(1):19-26. PubMed ID: 5405877
    [No Abstract]   [Full Text] [Related]  

  • 20. Dihydrofolate reductase inhibitors as potential drugs.
    McCormack JJ
    Med Res Rev; 1981; 1(3):303-31. PubMed ID: 7050566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.